Sutro Biopharma Inc sell Bank of America Co.
Start price
19.05.25
/
50%
€0.77
Target price
19.05.26
€0.72
Performance (%)
-18.92%
Price
02.12.25
€0.62
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc shows a convincing performance of -18.92%. This prediction currently runs until 19.05.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sutro Biopharma Inc | - | - |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its price target lowered by analysts at Bank of America Co. from $1.00 to $0.80. They now have an "underperform" rating on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€0.85
14.03.25
14.03.25
€0.92
14.03.26
14.03.26
-26.12%
02.12.25
02.12.25
